Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Vonoprazan fumarate by Phathom Pharmaceuticals for Reflux Esophagitis (Gastroesophageal Reflux Disease): Likelihood of Approval
Vonoprazan fumarate is under clinical development by Phathom Pharmaceuticals and currently in Phase I for Reflux Esophagitis (Gastroesophageal Reflux Disease)....